CPMG Inc, Director, 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 69,745 shares at $24.88 ($1.7M) on 2017-12-13, disclosed to the SEC on 2017-12-28.
Open-market purchase of $1.7M RETA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.98 | 49 | $1K | 0.1% |
| 2 | $24.88 | 19,982 | $497K | 28.8% |
| 3 | $24.88 | 19,982 | $497K | 28.8% |
| 4 | $24.65 | 14,866 | $366K | 21.2% |
| 5 | $24.65 | 14,866 | $366K | 21.2% |
| Total | $24.78 avg | 69,745 |
| $1.7M |
| 100% |
| Filing → |
| RETA | BUY | 2019-11-18 | $7.4M | — | Filing → |
| RETA | BUY | 2018-12-12 | $13.2M | — | Filing → |
| RETA | BUY | 2017-12-29 | $484K | — | Filing → |